Anna Hassebroek - Concepedia

Concepedia

Author

Anna Hassebroek

National Marrow Donor Program ORCID

Also Known As

A. Hassebroek, Anna Hassebroek, Anna M. Hassebroek, Rizzo, J. Douglas

52

Publications

1.6K

Citations

16

H-Index

24

Concepts

All Affiliations

National Marrow Donor Program Medical College of Wisconsin Fred Hutch Cancer Center Virginia Tech Dana-Farber Cancer Institute

AH

About

Anna Hassebroek is an author at National Marrow Donor Program specializing in marrow transplantation, blood transplantation, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	127
2	Blood Transplantation	3	3	127
3	Public Health	2	2	95
4	Epidemiology	2	2	95
5	Health Sciences	1	1	32

Anna Hassebroek

×

18

Publications

1.6K

Citations

16

H-Index

	Year	Citations
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy Craig Kollman, Stephen R. Spellman, Mei-Jie Zhang, Blood	2015	341
Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors Theresa Hahn, Philip L. McCarthy, Anna Hassebroek, Journal of Clinical Oncology	2013	243
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis Mukta Arora, John P. Klein, Daniel J. Weisdorf, Blood	2011	155
Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation K. Scott Baker, Stella M. Davies, Navneet S. Majhail, Biology of Blood and Marrow Transplantation	2009	153
Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia Michael Boyiadzis, Mukta Arora, John P. Klein, Clinical Cancer Research	2014	127
Trends in Use of and Survival after Autologous Hematopoietic Cell Transplantation in North America, 1995-2005: Significant Improvement in Survival for Lymphoma and Myeloma during a Period of Increasing Recipient Age Philip L. McCarthy, Theresa Hahn, Anna Hassebroek, Biology of Blood and Marrow Transplantation	2013	112
Outcomes of Allogeneic Hematopoietic Cell Transplantation for Adolescent and Young Adults Compared with Children and Older Adults with Acute Myeloid Leukemia Navneet S. Majhail, Ruta Brazauskas, Anna Hassebroek, Biology of Blood and Marrow Transplantation	2011	66
Race and Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma Parameswaran Hari, Navneet S. Majhail, Mei-Jie Zhang, Biology of Blood and Marrow Transplantation Hematological MalignancyOncologyMarrow TransplantationTransplantationSimilar Probabilities	2009	64
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease David A. Jacobsohn, Mukta Arora, John P. Klein, Blood	2011	60
Long-Term Survival and Late Deaths after Hematopoietic Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism Mary Eapen, Kwang Woo Ahn, Paul J. Orchard, Biology of Blood and Marrow Transplantation	2012	40

Page 1